Skip to main content
. 2022 Apr 25;13:863959. doi: 10.3389/fphar.2022.863959

TABLE 2a.

Clinical observations—female rats.

REL-1017 Methadone MK-801 p
Dose (mg/kg/d)
0 20 40 80 20 2
Number of animals 15 15 15 15 15 15 (MK801 vs. all)
Behavior/activity
 Activity decreased
  Number of times recorded 0 0 0 0 2 47
  Number of animals affected 2 15 <0.0001
 Ataxia
  Number of times recorded 0 0 0 0 0 28
  Number of animals affected 10 <0.0001
 Lateral recumbency
  Number of times recorded 0 0 0 0 0 3
  Number of animals affected 3 <0.05
 Salivation
  Number of times recorded 0 0 0 0 0 1
  Number of animals affected 1 ns
 Ventral recumbency
  Number of times recorded 0 0 0 0 2 20
  Number of animals affected 2 14 <0.0001
External Appearance
 Limb function impaired
  Number of times recorded 0 0 0 0 4 48
  Number of animals affected 1 10 <0.0001
 Material around eyes, black
  Number of times recorded 0 0 0 0 0 5
  Number of animals affected 3 <0.05
 Material around eyes, red
  Number of times recorded 0 0 1 0 0 11
  Number of animals affected 1 4 <0.05
 Material around nose, black
  Number of times recorded 0 0 0 0 0 2
  Number of animals affected 2 ns
 Material around nose, red
  Number of times recorded 0 1 0 1 0 5
  Number of animals affected 1 1 5 <0.01
 Thin
  Number of times recorded 0 1 1 1 1 24
  Number of animals affected 1 1 1 1 8 <0.0001
Pelage/Skin
 Hair wet
  Number of times recorded 0 0 0 0 0 3
  Number of animals affected 2 ns
 Skin discoloured, red
  Number of times recorded 0 0 0 0 0 5
  Number of animals affected 1 ns
 Skin discoloured, red/black
  Number of times recorded 0 0 0 0 0 1
  Number of animals affected 1 ns
Behaviour/activity
 Righting reflex impaired
  Number of times recorded 0 0 0 0 0 7
  Number of animals affected 7 <0.0001